Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Table of Contents

November 2016; Volume 36,Issue 11

Special Issue on New Anticancer Agents

Reviews

  • You have access
    MicroRNAs: A Puzzling Tool in Cancer Diagnostics and Therapy
    BARBARA D'ANGELO, ELISABETTA BENEDETTI, ANNAMARIA CIMINI and ANTONIO GIORDANO
    Anticancer Research November 2016, 36 (11) 5571-5575;
  • You have access
    Therapeutic Innovations for Targeting Hepatoblastoma
    AGNÈS GARNIER, MATTHIAS ILMER, ROLAND KAPPLER and MICHAEL BERGER
    Anticancer Research November 2016, 36 (11) 5577-5592;
  • You have access
    Cancer Immunology and Immunotherapy
    AMMAR SUKARI, MISAKO NAGASAKA, AMEER AL-HADIDI and LAWRENCE G. LUM
    Anticancer Research November 2016, 36 (11) 5593-5606;
  • You have access
    Immune Blockade Inhibition in Breast Cancer
    IOANNIS A. VOUTSADAKIS
    Anticancer Research November 2016, 36 (11) 5607-5622;
  • You have access
    Discovery of Anticancer Agents of Diverse Natural Origin
    A. DOUGLAS KINGHORN, ESPERANZA J. CARCACHE DE BLANCO, DAVID M. LUCAS, H. LIVA RAKOTONDRAIBE, JIMMY ORJALA, D. DOEL SOEJARTO, NICHOLAS H. OBERLIES, CEDRIC J. PEARCE, MANSUKH C. WANI, BRENT R. STOCKWELL, JOANNA E. BURDETTE, STEVEN M. SWANSON, JAMES R. FUCHS, MITCHELL A. PHELPS, LIHUI XU, XIAOLI ZHANG and YOUNG YONGCHUN SHEN
    Anticancer Research November 2016, 36 (11) 5623-5637;
  • You have access
    Molecular Mechanisms of Anti-metastatic Activity of Curcumin
    YI DENG, ELISE VERRON and RAMIN ROHANIZADEH
    Anticancer Research November 2016, 36 (11) 5639-5647;
  • You have access
    The Antitumor Effect of Singlet Oxygen
    GEORG BAUER
    Anticancer Research November 2016, 36 (11) 5649-5663;
  • You have access
    Identification of Important Compounds Isolated from Natural Sources that Have Activity Against Multidrug-resistant Cancer Cell Lines: Effects on Proliferation, Apoptotic Mechanism and the Efflux Pump Responsible for Multi-resistance Phenotype
    LEONARD AMARAL, GABRIELLA SPENGLER and JOSEPH MOLNAR
    Anticancer Research November 2016, 36 (11) 5665-5672;
  • You have access
    Regulation of the Expression of Cytoplasmic Polyadenylation Element Binding Proteins for the Treatment of Cancer
    YUN CHEN, YA-HUI TSAI and SHENG-HONG TSENG
    Anticancer Research November 2016, 36 (11) 5673-5680;
  • You have access
    Targeting Cellular Signaling Pathways in Breast Cancer Stem Cells and its Implication for Cancer Treatment
    BRUNO RICARDO BARRETO PIRES, ÍSIS SALVIANO SOARES DE AMORIM, LAYANE DUARTE E SOUZA, JULIANA ALVES RODRIGUES and ANDRE LUIZ MENCALHA
    Anticancer Research November 2016, 36 (11) 5681-5691;
  • You have access
    Heart Peptide Hormones: Adjunct and Primary Treatments of Cancer
    DAVID L. VESELY
    Anticancer Research November 2016, 36 (11) 5693-5700;
  • You have access
    The Anticancer Activity of the Old Neuroleptic Phenothiazine-type Drug Thioridazine
    GABRIELLA SPENGLER, ÁKOS CSONKA, JOSEPH MOLNÁR and LEONARD AMARAL
    Anticancer Research November 2016, 36 (11) 5701-5706;
  • You have access
    Potential Anti-metastasis Natural Compounds for Lung Cancer
    PITHI CHANVORACHOTE, SUPAKARN CHAMNI, CHUANPIT NINSONTIA and PREEYAPORN PLAIMEE PHIBOONCHAIYANAN
    Anticancer Research November 2016, 36 (11) 5707-5717;
  • You have access
    Radium-223: Insight and Perspectives in Bone-metastatic Castration-resistant Prostate Cancer
    FEDERICA ELEONORA BURONI, MARCO GIOVANNI PERSICO, FRANCESCA PASI, LORENZO LODOLA, ROSANNA NANO and CARLO APRILE
    Anticancer Research November 2016, 36 (11) 5719-5730;

Experimental Studies

  • You have access
    The Effects of Histone Deacetylase Inhibitor and Calpain Inhibitor Combination Therapies on Ovarian Cancer Cells
    KAROLINA LAPINSKA, GENEVIEVE HOUSMAN, SHANNON BYLER, SARAH HEERBOTH, AMBER WILLBANKS, ANUJA OZA and SIBAJI SARKAR
    Anticancer Research November 2016, 36 (11) 5731-5742;
  • You have access
    Vanillin Analogues o-Vanillin and 2,4,6-Trihydroxybenzaldehyde Inhibit NFĸB Activation and Suppress Growth of A375 Human Melanoma
    ANNAMÁRIA MARTON, ERZSÉBET KÚSZ, CSONGOR KOLOZSI, VILMOS TUBAK, GIUSEPPE ZAGOTTO, KRISZTINA BUZÁS, LUIGI QUINTIERI and CSABA VIZLER
    Anticancer Research November 2016, 36 (11) 5743-5750;
  • You have access
    ITPP Treatment of RG2 Glioblastoma in a Rat Model
    KAROLINA FÖRNVIK, SHAIAN ZOLFAGHARI, LEIF G. SALFORD and HENRIETTA NITTBY REDEBRANDT
    Anticancer Research November 2016, 36 (11) 5751-5755;
  • You have access
    Antioxidant and Antiproliferative Properties of the Essential Oils of Satureja thymbra and Satureja parnassica and their Major Constituents
    ELENI FITSIOU, IOANNIS ANESTOPOULOS, KATERINA CHLICHLIA, ALEX GALANIS, IOANNIS KOURKOUTAS, MIHALIS I. PANAYIOTIDIS and AGLAIA PAPPA
    Anticancer Research November 2016, 36 (11) 5757-5763;
  • You have access
    Targeting the PI3K/PTEN/AKT/mTOR Pathway in Treatment of Sarcoma Cell Lines
    HUI JUN LIM, XIAOCHUN WANG, PHILIP CROWE, DAVID GOLDSTEIN and JIA-LIN YANG
    Anticancer Research November 2016, 36 (11) 5765-5771;
  • You have access
    Secreted Phosphoprotein 24 kD Inhibits Growth of Human Prostate Cancer Cells Stimulated by BMP-2
    LIFENG LAO, JIA SHEN, HAIJUN TIAN, QINGQIANG YAO, YAWEI LI, LIE QIAN, SAMUEL S. MURRAY and JEFFREY C. WANG
    Anticancer Research November 2016, 36 (11) 5773-5780;
  • You have access
    The Use of Toll-like Receptor 4 Agonist to Reshape the Immune Signature in Ovarian Cancer
    EVA VINDEVOGEL, THAÏS BAERT, ANAÏS VAN HOYLANDT, GODELIEVE VERBIST, GREETJE VANDE VELDE, ABHISHEK D. GARG, PATRICIA AGOSTINIS, IGNACE VERGOTE and AN COOSEMANS
    Anticancer Research November 2016, 36 (11) 5781-5792;
  • You have access
    In Vitro Generation of Murine Dendritic Cells for Cancer Immunotherapy: An Optimized Protocol
    THAÏS BAERT, ABHISHEK D. GARG, EVA VINDEVOGEL, ANAÏS VAN HOYLANDT, GODELIEVE VERBIST, PATRIZIA AGOSTINIS, IGNACE VERGOTE and AN COOSEMANS
    Anticancer Research November 2016, 36 (11) 5793-5801;
  • You have access
    Quantitative Structure-cytotoxicity Relationship of 3-Benzylidenechromanones
    YOSHIHIRO UESAWA, HIROSHI SAKAGAMI, HAJIME KAGAYA, MARIMO YAMASHITA, KOICHI TAKAO and YOSHIAKI SUGITA
    Anticancer Research November 2016, 36 (11) 5803-5812;
  • You have access
    Negative Impact of Total Body Irradiation on the Antitumor Activity of Rhenium-(I)-diselenoether
    PHILIPPE COLLERY, FRANCOIS SANTONI, AHMED MOHSEN, CAROLINE MIGNARD and DIDIER DESMAELE
    Anticancer Research November 2016, 36 (11) 5813-5819;
  • You have access
    Pulsed Electromagnetic Field with Temozolomide Can Elicit an Epigenetic Pro-apoptotic Effect on Glioblastoma T98G Cells
    FRANCESCA PASI, LORENZO FASSINA, MARIA EVELINA MOGNASCHI, GIUSEPPE LUPO, FRANCO CORBELLA, ROSANNA NANO and ENRICA CAPELLI
    Anticancer Research November 2016, 36 (11) 5821-5826;
  • You have access
    Isoflavone Extracts Enhance the Effect of Epidermal Growth Factor Receptor Inhibitors in NSCLC Cell Lines
    RITA AMBROSIO, MARIA NEVE OMBRA, CESARE GRIDELLI, GIANLUCA PICARIELLO, MICHELE DI STASIO and MARIA G. VOLPE
    Anticancer Research November 2016, 36 (11) 5827-5833;
  • You have access
    Monensin Induces PC-3 Prostate Cancer Cell Apoptosis via ROS Production and Ca2+ Homeostasis Disruption
    SANG-HUN KIM, KWANG-YOUN KIM, SUN-NYOUNG YU, SUL-GI PARK, HAK-SUN YU, YOUNG-KYO SEO and SOON-CHEOL AHN
    Anticancer Research November 2016, 36 (11) 5835-5843;
  • You have access
    Selective Toxicity of a Highly Potent Camptothecin Analogue: A Pilot Study with Glioblastoma Multiforme Cells
    GARRET YOUNT, LILIANA SOROCEANU, HUI-JUAN WANG, ERIC SINGER, ROMI YOUNT, TRAN LUU and LI-XI YANG
    Anticancer Research November 2016, 36 (11) 5845-5848;
  • You have access
    Co-treatment of LY294002 or MK-2206 with AZD5363 Attenuates AZD5363-induced Increase in the Level of Phosphorylated AKT
    AE-RAN CHOI, JU-HWA KIM, YEON HWA WOO, JI HYUN CHEON, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research November 2016, 36 (11) 5849-5858;
  • You have access
    Attenuation of Colchicine Toxicity in Drug-resistant Cancer Cells by Co-treatment with Anti-malarial Drugs
    AE-RAN CHOI, JU-HWA KIM, JI HYUN CHEON, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research November 2016, 36 (11) 5859-5866;
  • You have access
    Highly Halaven-resistant KBV20C Cancer Cells Can Be Sensitized by Co-treatment with Fluphenazine
    JI HYUN CHEON, BYUNG MU LEE, HYUNG SIK KIM and SUNGPIL YOON
    Anticancer Research November 2016, 36 (11) 5867-5874;
  • You have access
    Therapeutic Effects of Hybrid Liposomes Against Xenograft Mouse Model of Colorectal Cancer In Vivo Due to Long-term Accumulation
    HIDEAKI ICHIHARA, MASAKI OKUMURA and YOKO MATSUMOTO
    Anticancer Research November 2016, 36 (11) 5875-5882;
  • You have access
    Minodronic Acid in Combination with γδT Cells Induces Apoptosis of Non-small Cell Lung Carcinoma Cell Lines
    MOTOAKI YASUKAWA, TSUTOMU NAKAZAWA, TAKESHI KAWAGUCHI, NORIKAZU KAWAI, TAKAHIRO TSUJIMURA, TAKASHI TOJO and SHIGEKI TANIGUCHI
    Anticancer Research November 2016, 36 (11) 5883-5886;
  • You have access
    Ad-shWnt2b Vector Therapy Demonstrates Antitumor Activity in Orthotopic Intrapleural Models as Monitored with the In Vitro Imaging System (IVIS)
    MASASHI KOBAYASHI, CHENG-LONG HUANG, MAKOTO SONOBE, RYUTARO KIKUCHI and HIROSHI DATE
    Anticancer Research November 2016, 36 (11) 5887-5893;
  • You have access
    The Behavior and Role of Lipolysis-stimulated Lipoprotein Receptor, a Component of Tricellular Tight Junctions, in Head and Neck Squamous Cell Carcinomas
    KENICHI TAKANO, TAKUYA KAKUKI, KAZUFUMI OBATA, KAZUAKI NOMURA, RYO MIYATA, ATSUSHI KONDO, MAKOTO KUROSE, AKITO KAKIUCHI, YAKUTO KANEKO, TAKAYUKI KOHNO, TETSUO HIMI and TAKASHI KOJIMA
    Anticancer Research November 2016, 36 (11) 5895-5904;
  • You have access
    Tamoxifen Suppresses the Growth of Malignant Pleural Mesothelioma Cells
    CORMAC J. JENNINGS, NAJIHAH ZAINAL, IZYAN M. M. DAHLAN, ELAINE W. KAY, BRIAN J. HARVEY and WARREN THOMAS
    Anticancer Research November 2016, 36 (11) 5905-5913;
  • You have access
    New Treatment Options for Osteosarcoma – Inactivation of Osteosarcoma Cells by Cold Atmospheric Plasma
    DENIS GÜMBEL, NADINE GELBRICH, MARTIN WEISS, MATTHIAS NAPP, GEORG DAESCHLEIN, AXEL SCKELL, STEPHAN A. ENDER, AXEL KRAMER, MARTIN BURCHARDT, AXEL EKKERNKAMP and MATTHIAS B. STOPE
    Anticancer Research November 2016, 36 (11) 5915-5922;
  • You have access
    Gimeracil Exerts Radiosensitizing Effects on Oral Squamous Cell Carcinoma Cells In Vitro and In Vivo
    KOJI HARADA, TARANNUM FERDOUS and YOSHIYA UEYAMA
    Anticancer Research November 2016, 36 (11) 5923-5930;
  • You have access
    Cytotoxic Components Against Human Oral Squamous Cell Carcinoma Isolated from Andrographis paniculata
    RYUICHIRO SUZUKI, YASUAKI MATSUSHIMA, NORIYUKI OKUDAIRA, HIROSHI SAKAGAMI and YOSHIAKI SHIRATAKI
    Anticancer Research November 2016, 36 (11) 5931-5935;
  • You have access
    Cell Surface Antibody Retention Influences In Vivo Antitumor Activity Mediated by Antibody-dependent Cellular Cytotoxicity
    MASAHIRO IKEDA, KAZUNORI KATO, MIKI YAMAGUCHI, HIROFUMI HAMADA, KAZUYASU NAKAMURA and YOSHIYUKI SUGIMOTO
    Anticancer Research November 2016, 36 (11) 5937-5944;
  • You have access
    The Antitumor Effect of Single-domain Antibodies Directed Towards Membrane-associated Catalase and Superoxide Dismutase
    GEORG BAUER and MANFRED MOTZ
    Anticancer Research November 2016, 36 (11) 5945-5956;
  • You have access
    Investigation of Bioequivalence Between Brand-name and Generic Irinotecan Products
    KEN-ICHI SAITO, YUTAKA INOUE, YOJI IKEGAMI, IZUMI NANBO, MARI ONOZUKA, KAZUMI SANO, HISAHIRO YOSHIDA, TOSHIHIRO SAKAMOTO, EMI TATEBAYASHI, KEN-ICHI FUJITA, YASUTSUNA SASAKI and TAKAKI KITAZAWA
    Anticancer Research November 2016, 36 (11) 5957-5963;
  • You have access
    Novel Synthetic Mono-triazole Glycosides Induce G0/G1 Cell-cycle Arrest and Apoptosis in Cholangiocarcinoma Cells
    SUMALEE OBCHOEI, RUNGNAPHA SAEENG, CHAISIRI WONGKHAM and SOPIT WONGKHAM
    Anticancer Research November 2016, 36 (11) 5965-5973;
  • You have access
    Enhancing the Therapeutic Efficacy of 2-Deoxyglucose in Breast Cancer Cells Using Cell-cycle Synchronization
    SU JIN LEE, BOK-NAM PARK, JUNG HYUN ROH, YOUNG-SIL AN, HOON HUR and JOON-KEE YOON
    Anticancer Research November 2016, 36 (11) 5975-5980;
  • You have access
    Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma
    XURUI DAI, SUYANEE THONGCHOT, HASAYA DOKDUANG, WATCHARIN LOILOME, NARONG KHUNTIKEO, ATTAPOL TITAPUN, PITI UNGARREEVITTAYA, PUANGRAT YONGVANIT, ANCHALEE TECHASEN and NISANA NAMWAT
    Anticancer Research November 2016, 36 (11) 5981-5988;
  • You have access
    Cantharidin Impairs Cell Migration and Invasion of Human Lung Cancer NCI-H460 Cells via UPA and MAPK Signaling Pathways
    TE-CHUN HSIA, CHIEN-CHIH YU, YUNG-TING HSIAO, SHIN-HWAR WU, DA-TIAN BAU, HSU-FENG LU, YI-PING HUANG, JAUNG-GENG LIN, SHU-JEN CHANG and JING-GUNG CHUNG
    Anticancer Research November 2016, 36 (11) 5989-5997;
  • You have access
    In Vitro and In Vivo Anticancer Activity of Human β-Defensin-3 and Its Mouse Homolog
    YOKO HANAOKA, YASUHIRO YAMAGUCHI, HIROSHI YAMAMOTO, MASAKI ISHII, TAKAHIDE NAGASE, HIROKI KURIHARA, MASAHIRO AKISHITA and YASUYOSHI OUCHI
    Anticancer Research November 2016, 36 (11) 5999-6004;
  • You have access
    Anticancer Effects of a New Aminosugar-conjugated Platinum Complex Agent Against Cisplatin-resistant Gastric Cancer
    NORIYUKI HAYASHI, HIROMI KATAOKA, SHIGENOBU YANO, JUN-ICHI KIKUCHI, MAMORU TANAKA, HIROTADA NISHIE, YUMA KINOSHITA, MIKI HATANO, AKIHIRO NOMOTO, AKIYA OGAWA, MASAHIRO INOUE, TSUTOMU MIZOSHITA, TAKAYA SHIMURA, YOSHINORI MORI, EIJI KUBOTA, SATOSHI TANIDA and TAKASHI JOH
    Anticancer Research November 2016, 36 (11) 6005-6009;
  • You have access
    Inhibition of the Pentose-phosphate Pathway Selectively Sensitizes Leukemia Lymphocytes to Chemotherapeutics by ROS-independent Mechanism
    ZHIVKO ZHELEV, DONIKA IVANOVA, RUMIANA BAKALOVA, ICHIO AOKI and TATSUYA HIGASHI
    Anticancer Research November 2016, 36 (11) 6011-6020;
  • You have access
    Inhibition of Glutaminolysis Inhibits Cell Growth via Down-regulating Mtorc1 Signaling in Lung Squamous Cell Carcinoma
    XULU YE, QILIANG ZHOU, YOSHIFUMI MATSUMOTO, MASATO MORIYAMA, SHUN KAGEYAMA, MASAAKI KOMATSU, SEIJIRO SATOH, MASANORI TSUCHIDA and YASUO SAIJO
    Anticancer Research November 2016, 36 (11) 6021-6029;
  • You have access
    Norcantharidin-induced Apoptosis of AGS Human Gastric Cancer Cells Through Reactive Oxygen Species Production, and Caspase- and Mitochondria-dependent Signaling Pathways
    LI-CHENG ZHENG, MEI-DUE YANG, CHAO-LIN KUO, CHIA-HSIN LIN, MING-JEN FAN, YU-CHENG CHOU, HSU-FENG LU, WEN-WEN HUANG, SHU-FEN PENG and JING-GUNG CHUNG
    Anticancer Research November 2016, 36 (11) 6031-6042;
  • You have access
    Dibenzoyl-methane Derivatives as a Potential and Exciting New Therapy for the Treatment of Childhood Bone Cancer
    EMAN ALMELAH, DAVID P. T. SMITH, ANDREW MCGOWN, ATHAR AZIZ, HERMAN J POTGIETER and PATRICIA RAGAZZON
    Anticancer Research November 2016, 36 (11) 6043-6050;
  • You have access
    Dose Effect of Rhenium (I)-diselenoether as Anticancer Drug in Resistant Breast Tumor-bearing Mice After Repeated Administrations
    PHILIPPE COLLERY, FRANÇOIS SANTONI, JOSEPH CICCOLINI, THI NGOC NGA TRAN, AHMED MOHSEN and DIDIER DESMAELE
    Anticancer Research November 2016, 36 (11) 6051-6057;
  • You have access
    Apoptosis of Hepatitis B Virus-expressing Liver Tumor Cells Induced by a High Concentration of Nucleos(t)ide Analogue
    EUNYOUNG TAK, SHIN HWANG, HAN CHU LEE, GI-YOUNG KO, CHUL-SOO AHN, YOUNG-IN YOON, YOUNG-SUK LIM, DAE-YOUNG JUN, KI-HUN KIM, GI-WON SONG, DEOG-BOK MOON, BAEK-YEOL RYOO, NAYOUNG KIM and SUNG-GYU LEE
    Anticancer Research November 2016, 36 (11) 6059-6069;
  • You have access
    Blockade of Androgen-induced Malignant Phenotypes by Flutamide Administration in Human Salivary Duct Carcinoma Cells
    YU KAMATA, TOMOKI SUMIDA, RYUICHI MURASE, HIROYUKI NAKANO, TOMOHIRO YAMADA and YOSHIHIDE MORI
    Anticancer Research November 2016, 36 (11) 6071-6075;
  • You have access
    Antitumor Effects of Eribulin Mesylate in Gemcitabine-resistant Pancreatic Cancer Cell Lines
    YUKA TAKEZAKI, TSUTOMU NAMIKAWA, TSUYOSHI KOYAMA, ERI MUNEKAGE, MASAYA MUNEKAGE, HIROMICHI MAEDA, HIROYUKI KITAGAWA and KAZUHIRO HANAZAKI
    Anticancer Research November 2016, 36 (11) 6077-6082;
  • You have access
    Impact of H3K27 Demethylase Inhibitor GSKJ4 on NSCLC Cells Alone and in Combination with Metformin
    HIKARU WATARAI, MASASHI OKADA, KENTA KURAMOTO, HIROYUKI TAKEDA, HIROTSUGU SAKAKI, SHUHEI SUZUKI, SHIZUKA SEINO, HIROYUKI OIZUMI, MITSUAKI SADAHIRO and CHIFUMI KITANAKA
    Anticancer Research November 2016, 36 (11) 6083-6092;
  • You have access
    Effect of Olmesartan on the Level of Oral Cancer Risk Factor PAI1
    STAVROS VASSILIOU, EMEKA NKENKE, NIKOS LEFANTZIS, ANASTASIOS IOANNIDIS, CHRISTOS YAPIJAKIS, MARGARITA ZOGA, VERONICA PAPAKOSTA, SPYRIDOULA DERKA, CHRYSSOULA NIKOLAOU and ELEFTHERIOS VAIRAKTARIS
    Anticancer Research November 2016, 36 (11) 6093-6096;
  • You have access
    FoxO3a is Essential for the Antiproliferative and Apoptogenic Effects of Sunitinib in MDA-MB231 Cell Line
    HESHAM M. KORASHY, OSAMAH M. BELALI, MUSHTAQ A. ANSAR and NAIF O. ALHARBI
    Anticancer Research November 2016, 36 (11) 6097-6108;
  • You have access
    Fisetin Reduces Cell Viability Through Up-Regulation of Phosphorylation of ERK1/2 in Cholangiocarcinoma Cells
    NAYOUNG KIM, SANG HYUB LEE, JUN HYUK SON, JAE MIN LEE, MIN-JUNG KANG, BO HYE KIM, JUNG-SU LEE, JI KON RYU and YONG-TAE KIM
    Anticancer Research November 2016, 36 (11) 6109-6116;
  • You have access
    Peroxisome Proliferator-activated Receptors as Potential Targets for Carcinogenic Activity of Polychlorinated Biphenyls: A Computational Perspective
    ISHFAQ AHMAD SHEIKH, ARWA ABU KHWEEK and MOHD AMIN BEG
    Anticancer Research November 2016, 36 (11) 6117-6124;
  • You have access
    In Silico Identification of Novel Erlotinib Analogues Against Epidermal Growth Factor Receptor
    ISHFAQ A. SHEIKH and HANI MUTLAK A. HASSAN
    Anticancer Research November 2016, 36 (11) 6125-6132;
  • You have access
    A Novel Aziridine-based Bruton's Tyrosine Kinase Inhibitor Induces Apoptosis Through Down-regulation of p65/RelA Phosphorylation on Serine 536 and ERK1/2 in Mantle Cell Lymphoma
    NADEZHDA ROMANCHIKOVA, ARNIS STRODS, JULIJA STRAZDINA, BORISS STRUMFS and PETERIS TRAPENCIERIS
    Anticancer Research November 2016, 36 (11) 6133-6140;

Clinical Studies

  • You have access
    Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer
    HARUO KATO, YOSUKE FURUYA, YOSHIYUKI MIYAZAWA, TAKESHI MIYAO, TAKAHIRO SYUTO, MASASHI NOMURA, YOSHITAKA SEKINE, HIDEKAZU KOIKE, HIROSHI MATSUI, YASUHIRO SHIBATA, KAZUTO ITO and KAZUHIRO SUZUKI
    Anticancer Research November 2016, 36 (11) 6141-6149;
  • You have access
    Imatinib-induced Gastrointestinal Vascular Ectasia in a Patient with Advanced GIST: Case Report and Literature Review
    MAHMOUD ABU-AMNA, HALIM AWADIE and GIL BAR-SELA
    Anticancer Research November 2016, 36 (11) 6151-6154;
  • You have access
    A Comparative Effectiveness Study of Two Oral Chemotherapy Drugs (UFT vs. Capecitabine) in Neoadjuvant Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer
    CHUN-RU CHIEN, WILLIAM TZU-LIANG CHEN, HWEI-MIN WANG, TAO-WEI KE, HUA-CHE CHIANG, SHENG-CHI CHANG, YU-CHUN HUANG, CHE-HUNG LIN, CHUN-LIN HUANG, YING-CHUN LIN, TSUNG-WEI CHEN, CHIA-CHIN LI and K.S. CLIFFORD CHAO
    Anticancer Research November 2016, 36 (11) 6155-6160;
  • You have access
    Treatment of Advanced Malignant Uterine Perivascular Epithelioid Cell Tumor with mTOR Inhibitors: Single-institution Experience and Review of the Literature
    KRISTEN D. STARBUCK, RICHARD D. DRAKE, G. THOMAS BUDD and PETER G. ROSE
    Anticancer Research November 2016, 36 (11) 6161-6164;
  • You have access
    The Influence of Neoadjuvant Chemotherapy with Docetaxel, Nedaplatin and 5-Fluorouracil After Esophagectomy
    SHINICHI ASAKA, TAKESHI SHIMAKAWA, KENTARO YAMAGUCHI, MINORU MURAYAMA, ASAKO SHIMAZAKI, TAKAO KATSUBE and YOSHIHIKO NARITAKA
    Anticancer Research November 2016, 36 (11) 6165-6171;
  • You have access
    Clinical Significance of the Histoculture Drug Response Assay in Breast Cancer
    YOSHIAKI SHINDEN, YUKO KIJIMA, MUNETSUGU HIRATA, HIDEO ARIMA, AKIHIRO NAKAJYO, KIYONORI TANOUE, KOSEI MAEMURA and SHOJI NATSUGOE
    Anticancer Research November 2016, 36 (11) 6173-6178;
  • You have access
    Sorafenib Combined with Radio-frequency Ablation Compared with Sorafenib Alone in Treatment of Hepatocellular Carcinoma Invading Portal Vein: A Western Randomized Controlled Trial
    ANTONIO GIORGIO, MARIA GABRIELLA MEROLA, LUCA MONTESARCHIO, FRANCESCA MEROLA, BRUNO SANTORO, CARMINE COPPOLA, PIETRO GATTI, FERDINANDO AMENDOLA, ANTONELLA DI SARNO, ANDREA CALVANESE, PAOLO MATTEUCCI and VALENTINA GIORGIO
    Anticancer Research November 2016, 36 (11) 6179-6183;
  • You have access
    Phase I Study of the Pan-PI3K Inhibitor Buparlisib in Adult Chinese Patients with Advanced Solid Tumors
    YI-LONG WU, LI ZHANG, LUCIA TRANDAFIR, TUOCHUAN DONG, VINCENT DUVAL, KATHARINE HAZELL and BINGHE XU
    Anticancer Research November 2016, 36 (11) 6185-6194;
  • You have access
    Reduction in Proportion of Senescent CD8+ T Lymphocytes During Chemotherapy of Children with Acute Lymphoblastic Leukemia
    VILMA RUTKAUSKAITĖ, LINA RAGELIENĖ, RĖDA MATUZEVIČIENĖ, KATAŽINA SINKEVIČ, MYKOLAS MAURICAS and DAINIUS CHARACIEJUS
    Anticancer Research November 2016, 36 (11) 6195-6199;
  • You have access
    New Drug and Possible New Toxicity – Squamous Cell Carcinoma Following Imatinib in Patients with Gastrointestinal Stromal Tumors
    FAISAL INAYAT and MUHAMMAD WASIF SAIF
    Anticancer Research November 2016, 36 (11) 6201-6204;

Errata

  • You have access
    Errata
    Anticancer Research November 2016, 36 (11) 6205;
Back to top
PreviousNext

In this issue

Anticancer Research
Vol. 36, Issue 11
November 2016
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Sign up for alerts

Jump to

  • Reviews
  • Experimental Studies
  • Clinical Studies
  • Errata
  • Top Topics
  • Most Cited
  • Most Read
Loading
Role of Resveratrol in Prevention and Therapy of Cancer: Preclinical and Clinical Studies
The Association of Solar Ultraviolet B (UVB) with Reducing Risk of Cancer: Multifactorial Ecologic Analysis of Geographic Variation in Age-adjusted Cancer Mortality Rates
Epithelial−Mesenchymal Transition in EGFR-TKI Acquired Resistant Lung Adenocarcinoma
Vitamin D Supplement Doses and Serum 25-Hydroxyvitamin D in the Range Associated with Cancer Prevention
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire